Journal of immunology and regenerative medicine最新文献

筛选
英文 中文
A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom 十年进展:英国再生医学研究的成就与未来挑战
Journal of immunology and regenerative medicine Pub Date : 2024-03-11 DOI: 10.1016/j.regen.2024.100078
Annabel J. Curle , Josephine L. Barnes , Robert Owen , Roger A. Barker , Alicia El Haj , Stuart J. Forbes , Cedric Ghevaert , Richard OC. Oreffo , Felicity RAJ. Rose , Molly M. Stevens , Zoe Hewitt
{"title":"A decade of progress: Achievements and future challenges for regenerative medicine research in the United Kingdom","authors":"Annabel J. Curle ,&nbsp;Josephine L. Barnes ,&nbsp;Robert Owen ,&nbsp;Roger A. Barker ,&nbsp;Alicia El Haj ,&nbsp;Stuart J. Forbes ,&nbsp;Cedric Ghevaert ,&nbsp;Richard OC. Oreffo ,&nbsp;Felicity RAJ. Rose ,&nbsp;Molly M. Stevens ,&nbsp;Zoe Hewitt","doi":"10.1016/j.regen.2024.100078","DOIUrl":"https://doi.org/10.1016/j.regen.2024.100078","url":null,"abstract":"<div><p>The final United Kingdom Regenerative Medicine Platform (UKRMP) conference held in Edinburgh's iconic McEwan Hall between 8th and November 10, 2023 saw a gathering of nearly 200 international delegates presenting exceptional science and celebrating a decade of this initiative. The UKRMP had the core mission to break down the major barriers to clinical translation of regenerative medicine products. UKRMP2 was established as three hubs that worked closely with industry and regulators: 1) Pluripotent Stem Cells and Engineered Cells, 2) Engineered Cell Environments, and 3) Smart Materials. In this meeting report, we outline the original aims of UKRMP, examine how it achieved critical mass, summarise the major developments that the UKRMP hubs delivered, and examine some unresolved challenges that still lie ahead in the field of regenerative medicine.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"24 ","pages":"Article 100078"},"PeriodicalIF":0.0,"publicationDate":"2024-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468498824000027/pdfft?md5=34a511e59647290cfb705cc6456747e9&pid=1-s2.0-S2468498824000027-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140160672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The past, present, and future promise of pluripotent stem cells 多能干细胞的过去、现在和未来前景
Journal of immunology and regenerative medicine Pub Date : 2024-02-01 DOI: 10.1016/j.regen.2024.100077
Jiwon Seo, Sayandeep Saha, Matthew E. Brown
{"title":"The past, present, and future promise of pluripotent stem cells","authors":"Jiwon Seo, Sayandeep Saha, Matthew E. Brown","doi":"10.1016/j.regen.2024.100077","DOIUrl":"https://doi.org/10.1016/j.regen.2024.100077","url":null,"abstract":"","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"22 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139814361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The past, present, and future promise of pluripotent stem cells 多能干细胞的过去、现在和未来前景
Journal of immunology and regenerative medicine Pub Date : 2024-02-01 DOI: 10.1016/j.regen.2024.100077
Jiwon Seo , Sayandeep Saha , Matthew E. Brown
{"title":"The past, present, and future promise of pluripotent stem cells","authors":"Jiwon Seo ,&nbsp;Sayandeep Saha ,&nbsp;Matthew E. Brown","doi":"10.1016/j.regen.2024.100077","DOIUrl":"10.1016/j.regen.2024.100077","url":null,"abstract":"","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"22 ","pages":"Article 100077"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468498824000015/pdfft?md5=e7ce5f2b685c8eaaa718e56c655a58fa&pid=1-s2.0-S2468498824000015-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139874244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expanding the horizons of cell-based immunotherapies: CAR-neutrophils 拓展细胞免疫疗法的视野:CAR中性粒细胞
Journal of immunology and regenerative medicine Pub Date : 2023-08-01 DOI: 10.1016/j.regen.2023.100076
Kaitlyn Sadtler
{"title":"Expanding the horizons of cell-based immunotherapies: CAR-neutrophils","authors":"Kaitlyn Sadtler","doi":"10.1016/j.regen.2023.100076","DOIUrl":"https://doi.org/10.1016/j.regen.2023.100076","url":null,"abstract":"","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"21 ","pages":"Article 100076"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50194046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xenotransplantation – has its time finally arrived? 异种移植——时机终于到了吗?
Journal of immunology and regenerative medicine Pub Date : 2023-08-01 DOI: 10.1016/j.regen.2023.100075
David K.C. Cooper
{"title":"Xenotransplantation – has its time finally arrived?","authors":"David K.C. Cooper","doi":"10.1016/j.regen.2023.100075","DOIUrl":"https://doi.org/10.1016/j.regen.2023.100075","url":null,"abstract":"<div><h3>Objectives</h3><p><span>The continuing shortage of organs from deceased human donors prevents many patients with end-stage organ failure from receiving an organ transplant. </span>Xenotransplantation, specifically the transplantation of organs from gene-edited pigs, might resolve the problem of organ supply.</p></div><div><h3>Key findings</h3><p><span>When transplanted into nonhuman primates, wild-type (i.e., genetically-unmodified) pig organs are rejected within minutes or hours by antibody-dependent complement-mediated injury and the effect of innate immune cells<span>. With regard to the transplantation of pig kidneys and hearts (but not yet of livers or lungs), this response has largely been overcome by judicious gene-editing of the organ-source pig. Pigs with 10 or more gene edits are now available. However, the adaptive immune response<span> to the graft still needs to be suppressed. Conventional immunosuppressive therapy, e.g., tacrolimus-based, is largely unsuccessful, whereas agents that block the CD40/CD154 </span></span></span>T cell co-stimulation pathway are more effective.</p></div><div><h3>Conclusions</h3><p>The combination of gene-edited pig organs and co-stimulation blockade has extended life-supporting pig kidney survival to months or years and pig heart survival to a maximum of 9 months. However, <em>consistent</em><span> survival cannot yet be guaranteed and this needs to be achieved before formal clinical trials<span><span> are initiated. Selection of patients for the initial clinical trials will be important. Patients aged 55–65 years with no or minimal comorbidities who are unlikely ever to receive a deceased human donor kidney would seem suitable candidates. Infants with life-threatening complex congenital heart disease who could be successfully bridged by a pig heart until an </span>allograft<span> became available would appear suitable candidates for pig heart transplantation.</span></span></span></p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"21 ","pages":"Article 100075"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50194048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Engineered anti-prostate cancer CAR-neutrophils from human pluripotent stem cells 来自人类多能干细胞的工程化抗前列腺癌症CAR-营养因子
Journal of immunology and regenerative medicine Pub Date : 2023-05-01 DOI: 10.1016/j.regen.2023.100074
Jackson D. Harris , Yun Chang , Ramizah Syahirah , Xiaojun Lance Lian , Qing Deng , Xiaoping Bao
{"title":"Engineered anti-prostate cancer CAR-neutrophils from human pluripotent stem cells","authors":"Jackson D. Harris ,&nbsp;Yun Chang ,&nbsp;Ramizah Syahirah ,&nbsp;Xiaojun Lance Lian ,&nbsp;Qing Deng ,&nbsp;Xiaoping Bao","doi":"10.1016/j.regen.2023.100074","DOIUrl":"10.1016/j.regen.2023.100074","url":null,"abstract":"<div><p><span><span><span><span>Immunotherapy is a powerful technique where </span>immune cells<span><span> are modified to improve cytotoxicity against cancerous cells to treat cancers that do not respond to surgery, chemotherapy, or radiotherapy. Expressing </span>chimeric antigen receptor<span> (CAR) in immune cells, typically T lymphocytes, is a practical modification that drives an immune response against cancerous tissue. CAR-T efficacy is suboptimal in </span></span></span>solid tumors<span><span> due to the tumor microenvironment (TME) that limits T lymphocyte cytotoxicity. In this study, we demonstrate that </span>neutrophils<span> differentiated from human pluripotent stem cells modified with AAVS1-inserted CAR constructs showed a robust cytotoxic effect against prostate-specific membrane antigen (PSMA) expressing LNCaP cells as a model for </span></span></span>prostate cancer </span><em>in vitro</em>. Our results suggest that engineered CARs can significantly enhance the neutrophil anti-tumor effect, providing a new avenue in treating prostate cancers.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"20 ","pages":"Article 100074"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121188/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9387846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
The gastroesophageal junction – A gap in tissue engineering 胃食管交界处——组织工程中的一个空白
Journal of immunology and regenerative medicine Pub Date : 2023-05-01 DOI: 10.1016/j.regen.2023.100073
Caleb Vogt , Ilitch Diaz-Gutierrez , Angela Panoskaltsis-Mortari
{"title":"The gastroesophageal junction – A gap in tissue engineering","authors":"Caleb Vogt ,&nbsp;Ilitch Diaz-Gutierrez ,&nbsp;Angela Panoskaltsis-Mortari","doi":"10.1016/j.regen.2023.100073","DOIUrl":"https://doi.org/10.1016/j.regen.2023.100073","url":null,"abstract":"<div><p><span><span>The gastroesophageal junction (GEJ) plays a critical role in preventing reflux of stomach contents into the esophagus and airways, but currently there are no options for replacement. Surgical resection of the GEJ or lower esophagus requires </span>reanastomosis through a gastric conduit or intestinal interposition, but these surgeries are associated with significant morbidity and mortality related to loss of the one-way valve function. Despite significant progress made in tissue-engineering for the body of the esophagus, little has been done for the stomach and no attempts have been made to reconstruct a GEJ. A detailed understanding of the GEJ </span>anatomy<span> and physiology complemented by knowledge of approaches used in tissue engineering of the esophagus and stomach is foundational to future attempts to address this gap in the field. These topics, as well as anticipated obstacles, are addressed in this review.</span></p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"20 ","pages":"Article 100073"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50194044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early tissue growth and cell fate determination following segmental esophageal repair using a tissue engineered esophageal implant composed of a polyurethane scaffold seeded with autologous adipose-derived mesenchymal stromal cells 应用组织工程食管植入物修复段性食管后早期组织生长和细胞命运的测定,该食管植入物由含有自体脂肪来源间充质基质细胞的聚氨酯支架组成
Journal of immunology and regenerative medicine Pub Date : 2023-02-01 DOI: 10.1016/j.regen.2022.100068
Sumati Sundaram , Karissa L. Paquin , Tina Roffidal , Greg Booker , Sherif Soliman , Jeff Bouchard , Elisaveta Todorova , Brett G. Zani , Raffaele Melidone , Saverio La Francesca , William Fodor
{"title":"Early tissue growth and cell fate determination following segmental esophageal repair using a tissue engineered esophageal implant composed of a polyurethane scaffold seeded with autologous adipose-derived mesenchymal stromal cells","authors":"Sumati Sundaram ,&nbsp;Karissa L. Paquin ,&nbsp;Tina Roffidal ,&nbsp;Greg Booker ,&nbsp;Sherif Soliman ,&nbsp;Jeff Bouchard ,&nbsp;Elisaveta Todorova ,&nbsp;Brett G. Zani ,&nbsp;Raffaele Melidone ,&nbsp;Saverio La Francesca ,&nbsp;William Fodor","doi":"10.1016/j.regen.2022.100068","DOIUrl":"https://doi.org/10.1016/j.regen.2022.100068","url":null,"abstract":"<div><h3>Introduction</h3><p>End-stage or chronic esophageal disease may eventually lead to surgical intervention and could potentially result in an esophagectomy, followed by a gastric pull-up or colon interposition procedure. Biostage's Cellspan™ Esophageal Implant (CEI) is designed to repair and replace full-circumferential esophageal surgical resections (≤6 cm) using autologous adipose derived mesenchymal stromal cells (Ad-MSCs) seeded on a retrievable polyurethane scaffold. The use of a segmental implant has the advantage of preserving the native non-diseased esophageal tissue as well as the stomach or intestinal tissue following esophagectomy. The mechanism of action, the fate of the Ad-MSC component (biodistribution) and the process of early tissue regrowth/wound repair following implantation remains to be elucidated.</p></div><div><h3>Methods</h3><p>CEIs seeded with Ad-MSCs transduced with green fluorescent protein (GFP) were implanted into a pig model of esophageal segmental resection. A 5 cm full-circumferential esophageal resection was performed followed by CEI implantation using an end-to-end anastomoses to bridge the gap between the 2 native esophageal ends. Cell fate and tissue development were assessed at 14 (N = 3), 21 (N = 3), and 28 days (N = 3), post-CEI implantation.</p></div><div><h3>Results</h3><p>All animals in all groups exhibited a contiguous biologic esophageal conduit with a denuded patent lumen at necropsy. Epithelial cell proliferation/regrowth was evident from both anastomotic margins toward the implant center. Morphometric analysis indicated an increase in epithelial regrowth and a concomitant reduction in denuded tissue from day 14 to day 28. Histological evaluation revealed fibrovascular tissue and neovascularization on the adventitial side, with no discernible differences in tissue organization between 14 and 28 day implants. The majority of GFP + cells were on the abluminal esophageal surface and localized around vascular structures. No GFP + cells were detected in lymph nodes or on retrieved scaffolds.</p></div><div><h3>Conclusion</h3><p>These findings support luminal continuity by day 14 post-implantation with Ad-MSC derived pericytes contributing to the neo-fibrovascular tissue. Morphometric analysis of the lumenal surface indicates that the process of lumenal re-epithelialization results from epithelial cell proliferation from the implant margins towards the center of the implant.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"19 ","pages":"Article 100068"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49871809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calcium phosphate with submicron topography influences primary human macrophage response, enhancing downstream angiogenesis and osteogenesis in vitro 亚微米形貌的磷酸钙影响原代人巨噬细胞反应,促进下游血管生成和体外成骨
Journal of immunology and regenerative medicine Pub Date : 2023-02-01 DOI: 10.1016/j.regen.2023.100070
L.A. van Dijk , L. Utomo , H. Yuan , F. Barrère-de Groot , D. Gawlitta , A.J.W.P. Rosenberg , J.D. de Bruijn
{"title":"Calcium phosphate with submicron topography influences primary human macrophage response, enhancing downstream angiogenesis and osteogenesis in vitro","authors":"L.A. van Dijk ,&nbsp;L. Utomo ,&nbsp;H. Yuan ,&nbsp;F. Barrère-de Groot ,&nbsp;D. Gawlitta ,&nbsp;A.J.W.P. Rosenberg ,&nbsp;J.D. de Bruijn","doi":"10.1016/j.regen.2023.100070","DOIUrl":"https://doi.org/10.1016/j.regen.2023.100070","url":null,"abstract":"<div><p>Calcium phosphates with submicron surface features have demonstrated superior performance to conventional calcium phosphates and equivalence to autologous bone in pre-clinical bone healing models. This is related to their ability to form bone in soft tissues, without the addition of cells and growth factors. It is hypothesized that a specific innate immune response to submicron topography contributes to the enhanced bone healing by these materials. Upregulation of pro-healing, anti-inflammatory ‘M2’ macrophages versus pro-inflammatory ‘M1’ macrophages on submicron-structured calcium phosphates may be involved. In this <em>in vitro</em> study, the response of primary human macrophages to different calcium phosphate bone graft substitutes was assessed. Primary CD14<sup>+</sup> monocytes were isolated from human buffy coats and were seeded on two different calcium phosphate materials. The first material had a submicron topography of needle-shaped crystals (BCP<sub>&lt;μm</sub>) while the second material had no submicron topography (TCP). Macrophage M1/M2 phenotype characterization by protein and gene expression markers at 24 h and 72 h indicated overall stronger macrophage activation and subtle phenotypic skewing towards the M2 phenotype on BCP<sub>&lt;μm</sub> vs TCP. Moreover, macrophages exhibited an elongated morphology on BCP<sub>&lt;μm</sub>, which is associated with the M2 phenotype, while macrophages on TCP primarily exhibited a spherical morphology. Conditioned medium of macrophages cultured on BCP<sub>&lt;μm</sub> resulted in enhanced <em>in vitro</em> angiogenic tube formation and osteogenic differentiation of mesenchymal stromal cells, compared to conditioned medium from macrophages on TCP. Altogether, these findings suggest a potential role of M2 macrophage upregulation in the bone-induction mechanism of calcium phosphates with submicron surface topography.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"19 ","pages":"Article 100070"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49871810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term outcomes of regenerative treatment by endoscopic oral mucosal epithelial cell sheet transplantation for the prevention of esophageal stricture after endoscopic resection 内镜下口腔黏膜上皮细胞片移植再生治疗预防内镜切除后食管狭窄的远期疗效
Journal of immunology and regenerative medicine Pub Date : 2023-02-01 DOI: 10.1016/j.regen.2022.100067
Takeshi Ohki , Masaho Ota , Ryo Takagi , Teruo Okano , Masakazu Yamamoto
{"title":"Long-term outcomes of regenerative treatment by endoscopic oral mucosal epithelial cell sheet transplantation for the prevention of esophageal stricture after endoscopic resection","authors":"Takeshi Ohki ,&nbsp;Masaho Ota ,&nbsp;Ryo Takagi ,&nbsp;Teruo Okano ,&nbsp;Masakazu Yamamoto","doi":"10.1016/j.regen.2022.100067","DOIUrl":"https://doi.org/10.1016/j.regen.2022.100067","url":null,"abstract":"<div><h3>Introduction</h3><p>We reported the short-term outcomes of a regenerative medical treatment to prevent esophageal stricture after endoscopic submucosal dissection (ESD) using cultured tis oral mucosal epithelial cell sheets. This study investigated the long-term outcomes of this treatment.</p></div><div><h3>Methods</h3><p>Epithelial cells, isolated from the patient's own oral mucosal tissue, were cultured for 16 days using temperature-responsive culture dishes. Then, the autologous cell sheets were endoscopically transplanted onto the bed of the esophageal ulcer after endoscopic mucosal resection (EMR) and ESD. Results of 10 patients who underwent endoscopic transplantation of oral mucosal epithelial cell sheets from April 2008 through February 2022 were recorded. We analyzed the outcome, the cause, and the endoscopic findings.</p></div><div><h3>Results</h3><p>The median period of observation was 3761 days. No stricture was detected in any of the patients long-term. Two patients died because of pancreatic cancer and brainstem hemorrhage. One patient underwent chemo-radiotherapy for further treatment. The patients underwent surgery due to metastasis to the lymph nodes. Only the lymph nodes were dissected, and the esophagus remained intact. From the endoscopic findings: Melanosis was found at the transplanted site in a patient. Strong iodine staining was shown at the transplanted site in a patient. Transplantation of cultured oral mucosal epithelial cell sheets to prevent esophageal stricture has been proven to be a safe treatment. All patients showed no controlled esophageal stricture in the long term.</p></div>","PeriodicalId":94333,"journal":{"name":"Journal of immunology and regenerative medicine","volume":"19 ","pages":"Article 100067"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49871808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信